Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.

被引：66

作者：

Kudo, Masatoshi

Matilla, Ana

Santoro, Armando

Melero, Ignacio

Gracian, Antonio Cubillo

Acosta-Rivera, Mirelis

Choo, Su Pin

El-Khoueiry, Anthony B.

Kuromatsu, Ryoko

El-Rayes, Bassel F.

Numata, Kazushi

Itoh, Yoshito

Di Costanzo, Francesco

Crysler, Oxana V.

Reig, Maria

Shen, Yun

Neely, Jaclyn

Dela Cruz, Christine Marie

Baccan, Carlos

Sangro, Bruno

机构：

[1] Kindai Univ, Fac Med, Osaka, Japan

[2] Hosp Gen Univ Gregorio Maranon, Serv Digest, Madrid, Spain

[3] Ist Clin Humanitas, Rozzano, Italy

[4] Univ Navarra, Pamplona, Spain

[5] Hosp Univ HM Sanchinarro, CIOCC, Madrid, Spain

[6] Fdn Invest, San Juan, PR USA

[7] Natl Canc Ctr Singapore, Singapore, Singapore

[8] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA

[9] Kurume Univ Hosp, Fukuoka, Fukuoka, Japan

[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[11] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan

[12] Kyoto Prefectural Univ, Kyoto, Japan

[13] AOU Careggi, Florence, Italy

[14] Univ Michigan, Ann Arbor, MI 48109 USA

[15] Hosptial Clin Barcelona, CIBEREHD, Liver Unit, BCLC Grp, Barcelona, Spain

[16] Bristol Myers Squibb, Princeton, NJ USA

[17] Clin Univ Navarra, Pamplona, Spain

[18] CIBEREHD, Pamplona, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期

关键词：

D O I：

10.1200/JCO.2019.37.4_suppl.327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

327

引用

页数：2